Latest William K. Oh Stories
The Oncology Institute of Hope and Innovation announces the opening of the following clinical trial that may benefit some prostate cancer patients. Downey, CA
Data from Multiple Studies Include Potential Ability for Technology to Further Subtype Patients, Guide Treatment Decisions SAN DIEGO, Feb.
AFFINITY Trial to Continue as Planned Following Completion of Interim Futility Analysis BOTHELL, Wash. and VANCOUVER, British Columbia, Jan.
Key evaluation to inform the US Food and Drug Administration regulatory submission SYDNEY, Sept.
A genetic discovery out of the University of Pittsburgh School of Medicine is leading to a highly accurate test for aggressive prostate cancer and identifies new avenues for treatment.
LONDON, June 15, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:
Phase III Trial Now Recruiting Patients SANTA ROSA, Calif., April 15, 2014 /PRNewswire/ -- A phase III clinical trial conducted at the Meir Medical Center in Kfar-Saba, Israel is now
ResearchMoz.us include new market research report "Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H1 2014" to its huge